ENCOMPASS HEALTH CORPORATION
Ownership & governance
Executives 5Directors 10Avg age 62Avg tenure 7.3y
MT
Mark Tarr
Chief Executive Officer
Age 64Since 2016-12-28Profile →
+14
Executives5
MT
Mark Tarr→
Chief Executive Officer
Age 64Since 2016-12-28
DC
Douglas Coltharp→
Director of Finance/CFO
Age 64Since 2010-05-05
PT
Patrick Tuer→
Chief Operating Officer
Age 42Since 2025-04-23
EC
Elissa Charbonneau→
Chief Tech/Sci/R&D Officer
Age 66Since 2014-12-31
MM
Mark David Miller→
Investor Relations Contact
—Since 2021-09-06
Board of directors10
MT
Mark Tarr→
Director/Board Member
Age 64Since 2016-12-28
JH
Joan Herman→
Director/Board Member
Age 72Since 2013-01-24
LK
Leslye Katz→
Director/Board Member
Age 71Since 2013-01-24
NS
Nancy Schlichting→
Director/Board Member
Age 71Since 2017-12-10
GC
Gregory Carmichael→
Chairman
Age 64Since 2024-05-01
TW
Terrance Williams→
Director/Board Member
Age 57Since 2019-12-31
CR
Christopher Reidy→
Director/Board Member
Age 69Since 2021-09-30
KO
Kevin O'Connor→
Director/Board Member
Age 58Since 2022-03-29
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 10.15 % | 10,067,186 |
| Vanguard Portfolio Management LLC | 5 % | 4,959,545 |
| T. Rowe Price International Ltd. | 4.638 % | 4,600,549 |
| Vanguard Capital Management LLC | 4.502 % | 4,466,237 |
| Wellington Trust Co., NA | 3.88 % | 3,848,855 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Douglas Coltharp | Director of Finance/CFO | 2010-05-05 | - |
| Elissa Charbonneau | Chief Tech/Sci/R&D Officer | 2014-12-31 | - |
| Gregory Carmichael | Chairman | 2024-05-01 | - |
| Mark Tarr | Chief Executive Officer | 2016-12-28 | - |
| Patrick Tuer | Chief Operating Officer | 2025-04-23 | - |
| Cain Hayes | Director/Board Member | 2026-01-29 | - |
| Christopher Reidy | Director/Board Member | 2021-09-30 | - |
| Joan Herman | Director/Board Member | 2013-01-24 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 148.17Range 140–155Analysts 12
140Mean 148.17155
- Strong buy 1
- Buy 12
Broker actions40 of 130
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | 140 | 2026-08-10 |
| UBS | Maintained | Buy | 155 | 2026-08-07 |
| Truist Securities | Maintained | Buy | 150 | 2026-08-07 |
| Barclays | Maintained | Overweight | 144 | 2026-08-06 |
| TD Cowen | Initiated | Buy | 125 | 2026-05-28 |
| Barclays | Maintained | Overweight | 140 | 2026-05-05 |
| Barclays | Maintained | Overweight | 153 | 2026-02-06 |
| Barclays | Maintained | Overweight | 150 | 2025-10-30 |
| UBS | Maintained | Buy | 150 | 2025-10-02 |
| Keybanc | Maintained | Overweight | 140 | 2025-09-16 |
| B of A Securities | Maintained | Buy | 160 | 2025-09-10 |
| Truist Securities | Maintained | Buy | 140 | 2025-08-14 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.